The Lidocaine Hydrochloride and Epin, cataloged under National Stock Number 6505-00-055-5716, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Astra Pharmaceuticals Lp. Government technical data includes 7 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 2 commercial cross-references from 1 manufacturer, enabling identification through both NSN and commercial part number lookups. 9 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-00-055-5716 |
| Primary Part Number | NDC00186-0265-02 |
| Item Name | Lidocaine Hydrochloride and Epin |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Astra Pharmaceuticals Lp |
| Status | ACTIVE |
| Total Primary Container Quantity | 5 |
| Primary Container Content Quantity | 30.000 MILLILITERS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | AMPUL |
| Active Medicament Medicinal Strength | 0.005 MILLIGRAMS EPINEPHRINE PER MILLILITER AND 15.000 MILLIGRAMS LIDOCAINE HYDROCHLORIDE PER MILLILITER |
| Protective Storage Feature | SUBJECT TO DAMAGE BY FREEZING |
| Pharmaceutical Vehicle Type | AQUEOUS |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Part Number | Manufacturer |
|---|---|
| XYLOCAINE | Astra Pharmaceuticals Lp (USA) |
| NDC00186-0265-02 PRIMARY | Astra Pharmaceuticals Lp (USA) |
NSN 6505-00-055-5716 is a Lidocaine Hydrochloride and Epin, manufactured by Astra Pharmaceuticals Lp, classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-00-055-5716 has 2 cross-referenced part numbers: XYLOCAINE (Astra Pharmaceuticals Lp), NDC00186-0265-02 (Astra Pharmaceuticals Lp).
There are 9 known substitutes for 6505-00-055-5716: 6505-00-240-5365, 6505-00-576-8842, 6505-00-598-6115 and 6 more. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00186-0265-02: Total Primary Container Quantity: 5; Primary Container Content Quantity: 30.000 MILLILITERS; Special Features: EPINEPHRINE 1:200,000; W/BUFFER; Medical Designation and Grade: UNITED STATES PHARMACOPEIA. 9 total characteristics are documented in the Federal Logistics Information System.